Selman Moises, Lin Hung-Mo, Montaño Martha, Jenkins Audrey L, Estrada Andrea, Lin Zhenwu, Wang Guirong, DiAngelo Susan L, Guo Xiaoxuan, Umstead Todd M, Lang C Max, Pardo Annie, Phelps David S, Floros Joanna
Instituto Nacional de Enfermedades Respiratorias, México DF, México.
Hum Genet. 2003 Nov;113(6):542-50. doi: 10.1007/s00439-003-1015-4. Epub 2003 Sep 6.
Derangement in pulmonary surfactant or its components and alveolar collapse are common findings in idiopathic pulmonary fibrosis (IPF). Surfactant proteins play important roles in innate host defense and normal function of the lung. We examined associations between IPF and genetic polymorphic variants of surfactant proteins, SP-A1, SP-A2, SP-B, SP-C, and SP-D. One SP-A1 (6A(4)) allele and single nucleotide polymorphisms (SNPs) that characterize the 6A(4) allele, and one SP-B (B1580_C) were found with higher frequency ( P</=0.01) in nonsmoker and smoker IPF ( n=84) subgroups, respectively, compared with healthy controls ( n=194). To explore whether a tryptophan (present in 6A(4)) or an arginine (present in other SP-A1 alleles and in all SP-A2 alleles) at amino acid 219 alters protein behavior, two truncated proteins that varied only at amino acid 219 were oxidized by exposure to ozone. Differences in the absorption spectra (310-350 nm) between the two truncated recombinant SP-A proteins were observed both before and after protein oxidation, suggesting allele-specific aggregation differences attributable to amino acid 219. The SP-B SNP B1580_C (odds ratio:7.63; confidence interval:1.64-35.4; P</=0.01), to be a risk factor for IPF smokers, has also been shown to be a risk factor for other pulmonary diseases. The SP-C and SP-D SNPs and SP-B-linked microsatellite markers studied did not associate with IPF. These findings indicate that surfactant protein variants may serve as markers to identify subgroups of patients at risk, and we speculate that these contribute to IPF pathogenesis.
肺表面活性物质或其成分紊乱以及肺泡萎陷是特发性肺纤维化(IPF)的常见表现。表面活性物质蛋白在宿主固有防御和肺的正常功能中发挥重要作用。我们研究了IPF与表面活性物质蛋白SP-A1、SP-A2、SP-B、SP-C和SP-D的基因多态性变体之间的关联。与健康对照者(n = 194)相比,在非吸烟者和吸烟者IPF(n = 84)亚组中分别发现一种SP-A1(6A(4))等位基因以及表征6A(4)等位基因的单核苷酸多态性(SNP),和一种SP-B(B1580_C)的频率较高(P≤0.01)。为了探究第219位氨基酸处的色氨酸(存在于6A(4)中)或精氨酸(存在于其他SP-A1等位基因和所有SP-A2等位基因中)是否会改变蛋白质行为,将仅在第219位氨基酸处不同的两种截短蛋白暴露于臭氧中进行氧化。在蛋白质氧化前后均观察到两种截短的重组SP-A蛋白之间吸收光谱(310 - 350 nm)的差异,这表明第219位氨基酸可导致等位基因特异性聚集差异。SP-B SNP B1580_C(优势比:7.63;置信区间:1.64 - 35.4;P≤0.01)是IPF吸烟者的一个危险因素,也已被证明是其他肺部疾病的危险因素。所研究的SP-C和SP-D SNPs以及与SP-B相关的微卫星标记与IPF无关联。这些发现表明表面活性物质蛋白变体可能作为识别高危患者亚组的标志物,并且我们推测这些变体促成了IPF的发病机制。